BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1714015)

  • 1. Cardiocirculatory responses to AII and AVP in conscious rats.
    Hernandez I; Ingles AC; Pinilla JM; Quesada T; Carbonell LF
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):916-22. PubMed ID: 1714015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of angiotensin II and vasopressin in intact awake rats.
    Hernandez I; Inglés AC; Ruiz F; Quesada T; Carbonell LF
    Gen Pharmacol; 1994 May; 25(3):527-32. PubMed ID: 7926602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac and peripheral circulatory responses to angiotension and vasopressin in dogs.
    Lee RW; Standaert S; Lancaster LD; Buckley D; Goldman S
    J Clin Invest; 1988 Aug; 82(2):413-9. PubMed ID: 3403712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of noradrenaline, B-HT 920, methoxamine, angiotensin II and vasopressin on mean circulatory filling pressure in conscious rats.
    Pang CC; Tabrizchi R
    Br J Pharmacol; 1986 Oct; 89(2):389-94. PubMed ID: 2877700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic peptide reverses angiotensin-induced venoconstriction in dogs.
    Lee RW; Gay RG; Goldman S
    Am J Physiol; 1989 Oct; 257(4 Pt 2):H1062-7. PubMed ID: 2529779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin and angiotensin II in blood pressure control during isoflurane anesthesia in rats.
    Ullman J
    Acta Anaesthesiol Scand; 1999 Sep; 43(8):860-5. PubMed ID: 10492417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of ganglionic blockers to assess neurogenic pressor activity in conscious rats.
    Santajuliana D; Hornfeldt BJ; Osborn JW
    J Pharmacol Toxicol Methods; 1996 Feb; 35(1):45-54. PubMed ID: 8645881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of various angiotensin receptor antagonists on cardiovascular responses to angiotensin II in pithed rats.
    Zhang J; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 1994 Jul; 24(1):108-13. PubMed ID: 7521474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alpha 2-adrenergic stimulation with UK 14,304-18 on the heart and peripheral circulation of intact dogs.
    Algeo S; Appleton CP; Martin GV; Lee RW; Mulkey R; Olajos M; Goldman S
    J Cardiovasc Pharmacol; 1985; 7(6):1055-64. PubMed ID: 2418288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral circulatory control of preload-afterload mismatch with angiotensin in dogs.
    Lee RW; Lancaster LD; Buckley D; Goldman S
    Am J Physiol; 1987 Jul; 253(1 Pt 2):H126-32. PubMed ID: 3605358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart rate reflex responses during gestation in normotensive and spontaneously hypertensive rats following angiotensin II and vasopressin.
    Massicotte G; St-Louis J; Schiffrin EL
    Proc Soc Exp Biol Med; 1987 Dec; 186(3):294-8. PubMed ID: 3423017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference between intracarotid and intravenous infusions of angiotensin II on baroreflex sensitivity and vasopressin release in conscious rats.
    Fenoy FJ; Ubeda M; García-Estañ J; Quesada T
    Rev Esp Fisiol; 1987 Sep; 43(3):355-60. PubMed ID: 3423394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vasopressin on cardiovascular and renal functions and ANP release under plasma volume expansion.
    Ohta M; Kimura T; Ota K; Shoji M; Inoue M; Sato K; Yamamoto T; Yoshinaga K
    Tohoku J Exp Med; 1991 Oct; 165(2):115-29. PubMed ID: 1839872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pinacidil on arterial and venous resistances and mean circulatory filling pressure in rats.
    Waite RP; Lim SL; Pang CC
    Br J Pharmacol; 1995 Oct; 116(4):2322-6. PubMed ID: 8564267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular actions of vasopressin: baroreflex modulation in the conscious rat.
    Webb RL; Osborn JW; Cowley AW
    Am J Physiol; 1986 Dec; 251(6 Pt 2):H1244-51. PubMed ID: 3789178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of calcium membrane blockers on in vivo vasoconstrictor properties of norepinephrine, angiotensin II and vasopressin.
    Goldberg JP; Schrier RW
    Miner Electrolyte Metab; 1984; 10(3):178-83. PubMed ID: 6727804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of vasopressin compared with angiotensin II in conscious rats.
    Osborn JW; Skelton MM; Cowley AW
    Am J Physiol; 1987 Mar; 252(3 Pt 2):H628-37. PubMed ID: 3826404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
    Harkin CP; Pagel PS; Tessmer JP; Warltier DC
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective vasopressin inhibition in rats with heart failure decreases afterload and results in venodilatation.
    Raya TE; Gay RG; Goldman S
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1015-20. PubMed ID: 2262890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.